HHMI - Howard Hughes Medical Institute

HHMI announces the inaugural Freeman Hrabowski Scholars cohort — 31 exceptional early career faculty who have potential to become leaders in their research fields and to create diverse and inclusive lab environments in which everyone can thrive.

In a collection of 11 newly published research papers, genomics further proves its worth by identifying species at risk for extinction, predicting the appearance and performance of a legendary sled dog, and illuminating once-dark corners of evolution and biology.

HHMI’s new postdoc salary scale increases salaries for 96 percent of the nearly 300 HHMI-employed postdocs working in HHMI Investigator labs across the US. HHMI is also encouraging Investigators to use the new salary scale for all postdocs in their laboratories, including those who are not HHMI employees. To ease the transition, HHMI established a Postdoc Bridge Fund to assist Investigators in increasing their postdocs' salaries.

Thirteen project teams involving 70 scientists from 29 institutions are collaborating on basic research targeted at preparedness for future emerging pathogens that could threaten human health.

104 schools are receiving six-year grants as part of HHMI’s Inclusive Excellence 3 (IE3) initiative. IE3 challenges US colleges and universities to substantially and sustainably build capacity for student belonging, especially for those who have been historically excluded from the sciences.

HHMI is making the first grants in our Driving Change initiative, awarding $2.5 million each to six universities: Loyola Marymount University in Los Angeles, the Ohio State University, the University at Albany, University of Maryland Eastern Shore, University of Montana, and University of Virginia. 

Howard Hughes Medical Institute supports the journal eLife's new scientific publishing model.

The Royal Swedish Academy of Sciences announced today that HHMI Investigator Carolyn Bertozzi of Stanford University, Morten Meldal of the University of Copenhagen, and K. Barry Sharpless of the Scripps Research Institute are the recipients of the 2022 Nobel Prize in Chemistry for the development of click chemistry and bioorthogonal chemistry.

Scientists discover how fat triggers a gut-to-brain mechanism that drives us to keep consuming more of it. Their findings could one day lead to interventions to help treat obesity and associated disorders.